Benjamin Herzberg

Abstract PR014: Preliminary safety and anti-tumor activity of RMC-6291, a first-in-class, tri-complex KRASG12C(ON) inhibitor, in patients with or without prior KRASG12C(OFF) inhibitor treatment

Pasi A. Jänne, Frédéric Bigot, Kyriakos P. Papadopoulos et al. · Molecular Cancer Therapeutics · 2023 · 50 citations

Preliminary Safety, Pharmacotherapy, Tumor Biology +18

Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced <i>KRAS G12C</i>-Mutant Non–Small Cell Lung Cancer

Rohit Thummalapalli, Ezra Bernstein, Benjamin Herzberg et al. · JCO Precision Oncology · 2023 · 36 citations · Full text

Chromothripsis-Mediated Small Cell Lung Carcinoma

Natasha Rekhtman, Sam E. Tischfield, Christopher A. Febres‐Aldana et al. · Cancer Discovery · 2024 · 36 citations · Full text

Trial in progress: A phase 1, first-in-human, open-label, multicenter, dose-escalation and dose-expansion study of ASP3082 in patients with previously treated advanced solid tumors and KRAS G12D mutations.

Anthony W. Tolcher, Wungki Park, Judy S. Wang et al. · Journal of Clinical Oncology · 2023 · 32 citations

Pathology, Dose-expansion Study, Cancer Biology +20

Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases

Lindsay Caprio, Amit Dipak Amin, Kresimir Bestak et al. · Nature Medicine · 2025 · 27 citations · Full text

Tumor Heterogeneity, Spatial Genomic Landscape, Spatial Omics +10